LENZ Therapeutics Statistics
Total Valuation
LENZ has a market cap or net worth of $213.52 million. The enterprise value is -$45.76 million.
| Market Cap | 213.52M |
| Enterprise Value | -45.76M |
Important Dates
The next estimated earnings date is Wednesday, July 29, 2026, before market open.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LENZ has 31.35 million shares outstanding. The number of shares has increased by 10.33% in one year.
| Current Share Class | 31.35M |
| Shares Outstanding | 31.35M |
| Shares Change (YoY) | +10.33% |
| Shares Change (QoQ) | +0.91% |
| Owned by Insiders (%) | 2.65% |
| Owned by Institutions (%) | 70.05% |
| Float | 18.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.10 |
| Forward PS | 9.04 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 0.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.40, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.40 |
| Quick Ratio | 10.11 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.71% and return on invested capital (ROIC) is -33.59%.
| Return on Equity (ROE) | -49.71% |
| Return on Assets (ROA) | -31.22% |
| Return on Invested Capital (ROIC) | -33.59% |
| Return on Capital Employed (ROCE) | -47.96% |
| Weighted Average Cost of Capital (WACC) | 12.29% |
| Revenue Per Employee | $138,086 |
| Profits Per Employee | -$717,079 |
| Employee Count | 152 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LENZ has paid $502,000 in taxes.
| Income Tax | 502,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.75% in the last 52 weeks. The beta is 1.47, so LENZ's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | -78.75% |
| 50-Day Moving Average | 8.64 |
| 200-Day Moving Average | 21.18 |
| Relative Strength Index (RSI) | 35.49 |
| Average Volume (20 Days) | 814,203 |
Short Selling Information
The latest short interest is 11.10 million, so 35.39% of the outstanding shares have been sold short.
| Short Interest | 11.10M |
| Short Previous Month | 10.72M |
| Short % of Shares Out | 35.39% |
| Short % of Float | 60.04% |
| Short Ratio (days to cover) | 12.41 |
Income Statement
In the last 12 months, LENZ had revenue of $20.99 million and -$109.00 million in losses. Loss per share was -$3.66.
| Revenue | 20.99M |
| Gross Profit | 19.50M |
| Operating Income | -118.34M |
| Pretax Income | -108.49M |
| Net Income | -109.00M |
| EBITDA | -117.98M |
| EBIT | -118.34M |
| Loss Per Share | -$3.66 |
Balance Sheet
The company has $258.39 million in cash and $673,000 in debt, with a net cash position of $257.71 million or $8.22 per share.
| Cash & Cash Equivalents | 258.39M |
| Total Debt | 673,000 |
| Net Cash | 257.71M |
| Net Cash Per Share | $8.22 |
| Equity (Book Value) | 246.49M |
| Book Value Per Share | 7.86 |
| Working Capital | 242.56M |
Cash Flow
In the last 12 months, operating cash flow was -$86.70 million and capital expenditures -$735,000, giving a free cash flow of -$87.44 million.
| Operating Cash Flow | -86.70M |
| Capital Expenditures | -735,000 |
| Depreciation & Amortization | 362,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -87.44M |
| FCF Per Share | -$2.79 |
Margins
| Gross Margin | 92.88% |
| Operating Margin | -563.83% |
| Pretax Margin | -516.91% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LENZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.33% |
| Shareholder Yield | -10.33% |
| Earnings Yield | -51.42% |
| FCF Yield | -41.25% |
Analyst Forecast
The average price target for LENZ is $32.00, which is 369.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.00 |
| Price Target Difference | 369.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 93.33% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LENZ has an Altman Z-Score of 16.26 and a Piotroski F-Score of 1.
| Altman Z-Score | 16.26 |
| Piotroski F-Score | 1 |